Company Filing History:
Years Active: 2007-2009
Title: Weiduan Xu: Innovator in Angiogenesis and Tumorigenesis
Introduction
Weiduan Xu is a prominent inventor based in San Francisco, CA. He has made significant contributions to the fields of angiogenesis and tumorigenesis through his innovative research and patents. With a total of 5 patents, Xu's work focuses on the regulation of these critical biological processes.
Latest Patents
Xu's latest patents include groundbreaking inventions related to modulators of angiogenesis and tumorigenesis. One of his notable patents discusses methods for identifying and using agents, such as small organic molecules, antibodies, peptides, cyclic peptides, nucleic acids, antisense nucleic acids, RNAi, and ribozymes, that modulate angiogenesis via the modulation of endothelial cell haptotaxis. This invention also emphasizes the use of expression profiles and compositions in the diagnosis and therapy of angiogenesis and cancer. Another patent focuses specifically on the regulation of angiogenesis, detailing similar methods and applications.
Career Highlights
Weiduan Xu is currently associated with Rigel Pharmaceuticals, Incorporated, where he continues to advance his research in the biomedical field. His work has garnered attention for its potential impact on cancer treatment and understanding the mechanisms of angiogenesis.
Collaborations
Some of Xu's notable coworkers include Sacha Holland and James Bradley Lorens. Their collaborative efforts contribute to the innovative environment at Rigel Pharmaceuticals.
Conclusion
Weiduan Xu's contributions to the fields of angiogenesis and tumorigenesis highlight his role as a leading inventor in biomedical research. His patents reflect a commitment to advancing medical science and improving therapeutic strategies for cancer treatment.